FLUOROPHARMA MEDICAL, INC.
FLUOROPHARMA MEDICAL, INC. (FPMI): 2 pipeline candidates · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
0.8 months
0% dilution
Lead: Phase 2
2 candidates
N/A
N/A
A transparent, data-derived signal for FLUOROPHARMA MEDICAL, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$7K
Cash
$25K
Quarterly Burn
$116K
Runway
0.8 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
Frequently asked questions
How many drug candidates are in FLUOROPHARMA MEDICAL, INC.'s pipeline?
FLUOROPHARMA MEDICAL, INC. (FPMI) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is FLUOROPHARMA MEDICAL, INC.'s lead drug candidate?
FLUOROPHARMA MEDICAL, INC.'s most advanced tracked candidate is bfpet (Phase 2) for Stress-testing for patients with presumptive or proven CAD.
What is FLUOROPHARMA MEDICAL, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, FLUOROPHARMA MEDICAL, INC. has approximately 0.8 months of cash runway.
What is FLUOROPHARMA MEDICAL, INC.'s market capitalization?
FLUOROPHARMA MEDICAL, INC.'s market capitalization is approximately $7K.
Who is the CEO of FLUOROPHARMA MEDICAL, INC.?
Thomas H. Tulip, Ph.D. is the chief executive officer of FLUOROPHARMA MEDICAL, INC. (FPMI).
Get the full picture on FLUOROPHARMA MEDICAL, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.